BioArctic AB (publ) (STO:BIOA.B)

BioArctic AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	213.24	1,022	-177.08	229.25	-11.18	-119.79
Depreciation & Amortization	15.12	15.21	13.67	7.44	14.08	13.05
Stock-Based Compensation	24.04	24.04	19.33	16.14	2.76	1.57
Other Operating Activities	-15.7	195.27	-24.35	43.72	-62.21	-30.22
Change in Accounts Receivable	677.28	-64.77	-190.56	-11.98	-2.41	-5.12
Change in Other Net Operating Assets	339.28	238.99	42.66	25.13	27.33	0.06
Operating Cash Flow	1,253	1,431	-316.33	309.69	-31.64	-140.46
Capital Expenditures	-10.24	-10.24	-26.64	-7.44	-12.75	-4.39
Investment in Securities	-884.4	-884.4	232.27	-500.04	-0.02	-0.03
Other Investing Activities	284.17	-	0	-	0	0
Investing Cash Flow	-610.47	-894.65	205.63	-507.49	-12.76	-4.41
Long-Term Debt Issued	-	0.89	-	-	-	-
Long-Term Debt Repaid	-	-	-0.33	-0.92	-8.79	-7.39
Net Debt Issued (Repaid)	0.89	0.89	-0.33	-0.92	-8.79	-7.39
Issuance of Common Stock	26.01	26.01	6.02	14.98	5.99	-
Other Financing Activities	-1.73	-	-0	-0	-	-
Financing Cash Flow	25.18	26.9	5.69	14.06	-2.81	-7.39
Foreign Exchange Rate Adjustments	-21.82	-35.82	6.37	-10.09	4.19	0.72
Miscellaneous Cash Flow Adjustments	-	-	-0	-	-0	-
Net Cash Flow	646.16	527.5	-98.64	-193.82	-43.02	-151.54
Free Cash Flow	1,243	1,421	-342.97	302.25	-44.38	-144.84
Free Cash Flow Margin	108.36%	71.07%	-133.27%	49.07%	-19.35%	-564.40%
Free Cash Flow Per Share	14.00	16.01	-3.87	3.42	-0.50	-1.65
Cash Interest Paid	2.35	2.35	1.85	0.38	0.75	0.98
Cash Income Tax Paid	160.61	71.6	0.52	-0.16	-0.34	0.31
Levered Free Cash Flow	1,259	1,161	-287.35	210.92	-34.44	-91.07
Unlevered Free Cash Flow	1,259	1,162	-287.35	211.13	-34.09	-90.55
Change in Working Capital	1,017	174.22	-147.91	13.15	24.91	-5.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.